abstract |
The present invention not only significantly enhances anticancer activity than when Taxol alone is used, but also protects against immunotoxicity of Taxol, and when using high concentration of Taxol while using low concentration of Taxol, the same anticancer activity is obtained. The present invention provides an anticancer pharmaceutical composition comprising taxol and red ginseng acidic polysaccharide as an active ingredient. |